Alnylam Pharmaceuticals, Inc. Savings & Investment Plan is a defined contribution plan with a 401k feature. This plan has a BrightScope Rating of 82. This plan is in the top 15% of plans for Salary Deferral. Alnylam Pharmaceuticals, Inc. Savings & Investment Plan currently has over 200 active participants and over $10.7M in plan assets.
|1.||Fidelity Advisor New Insights||12%|
|2.||Alnylam Pharmaceuticals, Inc. Common Stock||9%|
300 Third Street
Cambridge, MA 02142
|Industry||Professional, Scientific, and Technical Services|
|Net Plan Assets||$10,700,000|
|Avg Account Balance||$51,000|
|Cato Research Ltd.||72.2|
|Minneapolis Medical Research...||62.5|
Please visit the vault to keep your 401k plan information accurate and up-to-date.